| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac9f22bc3bc8655b7477baf87e628a5c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
| filingDate |
2015-06-17^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-01-01^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5be83d1330e36bc925e9d1229f921b21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33ab78106d00ff0a86cf1a5e37354f33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1719f9591ed530d231f8953c362276b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2b3a6dfae7cbf099345edaff997a3d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f40fa1862e7897b218b5e96b55a0832f |
| publicationDate |
2019-01-01^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10166238-B2 |
| titleOfInvention |
EZH2 inhibitors for treating lymphoma |
| abstract |
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and their use for the treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642349-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202781-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019175604-A1 |
| priorityDate |
2014-06-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |